Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kainos Medicine Inc.
DescriptionSodium channel blocker
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationXerostomia
Indication DetailsTreat xerostomia (dry mouth) associated with Sjogren's syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today